One concern with in vivo CAR-Ts is the potential insertional mutagenesis of the lentiviral DNA payload, causing secondary ...

The 4th In Vivo Cell Engineering & Gene Editing Summit, taking place June 3–5, 2025 in Boston, is the definitive event ...

SageMedic Corp. (SAGE), a Silicon Valley pioneer in Functional Precision Oncology, announces significant advancements in personalized cancer therapy using its innovative SAGE Oncotest™, a ...

The following is a summary of "Heme-induced lung injury in human precision-cut lung slices: a new model for acute lung injury ...

The companies all use modified versions of the same lentiviral vectors used in ex vivo CAR-T therapy. “We're using the same basic vector backbone that's used to manufacture the cells ex vivo ...

PHILADELPHIA, PA — Interius BioTherapeutics has announced its participation in three key scientific gatherings this spring, ...

While technologies like mass spectrometry are powerful and widely used in metabolomics, they’re typically restricted to ex ...

NEW YORK – In cell and gene therapies, the genetic machinery is key to producing the proteins missing or dysregulated in a disease, but whether the therapeutic cassette reaches target cells and how ...

Different bore sizes for ex vivo samples, mice, rats and small rabbits. Equipped with a gas anesthesia system. A radiation survey meter available.